Skip to content

Inspiratory Muscle Training in Pulmonary Arterial Hypertension

Inspiratory Muscle Training in Pulmonary Arterial Hypertension

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04197388
Enrollment
20
Registered
2019-12-13
Start date
2019-06-26
Completion date
2021-04-01
Last updated
2019-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Hypertension

Brief summary

Pulmonary arterial hypertension is a rare condition characterised by high blood pressure in the lungs and results in breathlessness and reduced exercise capacity for patients. Previous research has shown weakness in respiratory muscles in these patients that may contribute towards their symptoms. Despite advances in medical therapy, the condition still results in a significant symptom burden. Inspiratory muscle training is a non-invasive intervention involving a device that provides resistance to the muscles of inspiration and increases their strength. This study will investigate the benefit of inspiratory muscle training in patients with pulmonary arterial hypertension who are stable on medical therapy for three months. This will be performed as an outpatient and they will then be reviewed following this with assessment of exercise capacity, breathing capacity (spirometry), quality of life, and assessment of neural respiratory drive (the signals from the brain to the muscles controlling breathing). The study will be based at the Golden Jubilee National Hospital and patients will be recruited from outpatients who are already under the care of the Scottish Pulmonary Vascular Unit.

Interventions

Inspiratory muscle training, 6 cycles of 30 breaths for 12 weeks.

Sponsors

Golden Jubilee National Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed by pulmonary hypertension specialist with precapillary pulmonary hypertension * able to give consent * stable on medical therapy for at least 3 months

Exclusion criteria

* significant contribution to pulmonary hypertension from lung disease * pregnant

Design outcomes

Primary

MeasureTime frame
Six minute walking distance3 months

Secondary

MeasureTime frameDescription
Quality of life: emPHasis 10 score3 monthsemPHasis 10 score
Peak VO23 monthsAssessed by cardiopulmonary exercise test
VE/VCO2 slope3 monthsAssessed by cardiopulmonary exercise test

Countries

United Kingdom

Contacts

Primary ContactPaul McCaughey
paulmccaughey@nhs.net07907029041

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026